SHILPAMED

Shilpa Medicare Ltd.

NSE: SHILPAMED

BSE: 530549

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

608.95+8.1 (+1.35%)

3 Jul, 3:30 PM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

68.3 / 100

Value Score

22.1 / 100

Price Momentum Score

96.1 / 100

QVM Score

73.6 / 100

Key Metrics

Market Cap

11751.50

P/E (TTM)

48.29

P/B

4.54

P/S (TTM)

3.82

EV/EBITDA

27.25

CAPE (5Y)

149.81

ROE (TTM)

9.80

ROCE (TTM)

8.81

ROA (TTM)

6.94

Avg 3Y ROE

5.11

Earnings 3Y CAGR

Sales 3Y CAGR

43.11

Sales 5Y CAGR

27.85

Debt/Equity

0.25

Consensus TP

580.00

Strong Buy %

66.67

Promoter Holding

40.13

Pledged %

8.73

Stock Analysis

Fundamental analysis overview of Shilpa Medicare Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 96.1 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

96.1 / 100

Strong revenue growth and above median growth of industry

The company delivered strong revenue growth of 139.25% for 12-month ended 31 Mar 2026 and the growth was 128.01 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 139.25

-82.35114662

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 209.61% for 12-month ended 31 Mar 2026 and the growth was 201.49 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.25 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 48.29 indicates that the stock is expensive on a standalone basis and is at a 59.58% premium to industry median P/E

What is P/E Ratio?

Median: 30.26

Value 48.29

-215.443183

Analysts have been downgrading forward EPS estimates

Analyst EPS estimate (consensus) for forward EPS has decreased by -23.84% in the last 3 months, indicating weak earnings momentum

What is Earnings upgrade (3M)?

Low dividend yield

The company has a low dividend yield of 0.08%

What is Dividend yield?

Neutral

Low ROE but improving trend

The company reported low ROE of 9.8% for 12-month ended 31 Mar 2026 but ROE improved by 605 bps from 1 year ago

What is ROE (FY)?

Company's earnings are of moderate quality

Earnings quality score of 62.5 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

62.5 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Shilpa Medicare Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Shilpa Medicare Ltd. Shareholding Pattern

Quarterly breakdown of Shilpa Medicare Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	53.80	53.80	53.25	53.25	53.25	53.25	53.25	50.01	50.01	50.01	50.01	50.01	50.01	50.01	50.01	50.01	50.01	44.39	44.33	44.23	44.23	44.23	44.23	40.13	40.13
Indian Promoter	53.80	53.80	53.25	53.25	53.25	53.25	53.25	50.01	50.01	50.01	50.01	50.01	50.01	50.01	50.01	50.01	50.01	44.39	44.33	44.23	44.23	44.23	44.23	40.13	40.13
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	26.93	26.84	19.48	19.45	20.64	18.08	15.18	17.45	16.34	16.40	16.22	15.94	14.28	10.63	9.01	8.58	7.28	16.69	17.76	18.17	18.52	18.64	18.57	19.30	19.66
Mutual Funds / UTI	0.00	-	2.79	2.28	2.95	2.05	2.29	2.12	1.01	1.01	1.01	0.05	-	-	0.04	0.06	1.55	5.03	5.09	4.89	4.05	4.05	4.26	5.20	5.15
FI/Bank/Insurance	0.47	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.25	1.61	1.86	2.08	1.97	1.98	1.79	2.03
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	19.09	19.03	15.90	16.21	16.23	14.56	12.27	14.59	14.41	14.41	10.98	11.84	10.25	10.26	8.60	8.52	5.63	9.08	9.59	9.90	10.97	11.19	10.92	10.97	11.08
Other Institutions	7.36	7.36	0.83	0.96	1.45	1.47	0.62	0.75	0.92	0.98	4.23	4.04	4.02	0.37	0.37	0.00	0.10	1.33	1.48	1.52	1.42	1.42	1.41	1.35	1.40
Non-Institution	19.26	19.36	27.27	27.30	26.12	28.68	31.57	32.54	33.65	33.59	33.77	34.04	35.71	39.37	40.99	41.41	42.71	38.92	37.90	37.60	37.25	37.13	37.20	40.56	40.21
Bodies Corporate	1.21	5.04	6.40	6.00	6.13	8.70	10.15	12.53	12.43	12.21	11.31	8.56	7.91	8.69	12.69	13.08	12.03	12.26	12.01	11.26	10.83	10.27	10.17	9.08	8.83
Others (incl. Retail) No. of shareholders	18.05 14,564	14.32 18,773	20.87 43,027	21.30 54,118	19.99 50,864	19.98 52,695	21.42 46,022	20.01 39,067	21.22 39,235	21.38 38,621	22.46 41,112	25.48 45,690	27.80 46,447	30.68 49,952	28.30 43,633	28.33 43,174	30.68 45,556	26.66 40,544	25.89 42,192	26.34 48,349	26.42 49,413	26.86 47,749	27.03 51,147	31.48 52,895	31.38 52,522

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	Nifty Microcap 250	0.7%	26 / 250
2	Nifty Total Market	0.03%	410 / 749

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Shilpa Medicare Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
PRIYA INANI Promoter Group	December-2024	Market Sale (Disposal) 13th Dec 2024	0.18 %	₹ 837.45	1.00 lac	₹ 8.37 cr
SURAJ KUMAR INANI Promoter Group	August-2024	Market Sale (Disposal) 27th Aug 2024	4.06 %	₹ 760.81	50.00 k	₹ 3.80 cr
SURAJ KUMAR INANI Promoter Group	August-2024	Market Sale (Disposal) 26th Aug 2024	4.07 %	₹ 700.03	10.00 k	₹ 70.00 lac
RAKESH KUMAR DOBA Designated Person	December-2023	Market Sale (Disposal) 19th Dec 2023	0.00 %	₹ 8.36	44.00	₹ 368.00
RAKESH KUMAR DOBA Designated Person	December-2023	Market Sale (Disposal) 19th Dec 2023	0.01 %	₹ 0.06	5.71 k	₹ 368.00
RAKESH KUMAR DOBA Designated Person	December-2023	Market Sale (Disposal) 19th Dec 2023	0.01 %	₹ 0.06	5.71 k	₹ 368.00
Mr. Suraj Kumar Innani Designated Person	October-2022	Market Purchase (Acquisition) 21st Oct 2022	4.59 %	₹ 339.88	3.01 k	₹ 10.24 lac
Mr. Suraj Kumar Innani Designated Person	October-2022	Market Sale (Disposal) 21st Oct 2022	4.59 %	₹ 335.77	3.01 k	₹ 10.12 lac
Mr. Alpesh Maheshkumar Dalal KMP	November-2021	Market Purchase (Acquisition) 18th Nov 2021	0.00 %	₹ 0.29	2.00 k	₹ 571.00

Corporate Actions

History of Shilpa Medicare Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Bonus1 new shares for 1 existing shares
Ex-date: 3rd Oct 2025Announced on: 13th Aug 2025
Dividend₹ 1/share
Record date: 17th Sep 2025Ex-date: 17th Sep 2025
Announced on: 26th May 2025
Dividend₹ 1.10/share
Record date: 20th Sep 2022Ex-date: 19th Sep 2022
Announced on: 23rd May 2022
Dividend₹ 1.10/share
Record date: 21st Sep 2021Ex-date: 20th Sep 2021
Announced on: 31st May 2021
Dividend₹ 1.10/share
Record date: 17th Mar 2020Ex-date: 16th Mar 2020
Announced on: 3rd Mar 2020

Company Profile

Overview of Shilpa Medicare Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products a...

Key personnel

Mr. Alpesh Maheshkumar Dalal

Chief Financial Officer

Ms. Ritu Tiwary

Compliance Officer, Company Secretary

Mr. Omprakash InaniD

Non-Executive Chairman of the Board

Mr. Vishnukant Chaturbhuj BhutadaD

Managing Director, Executive Director

Mr. Kalakota Sharath ReddyD

Whole-Time Director

Mr. Ashraf Loutfy Abdelhamid AllamD

Non-Executive Independent Director

Dr. Anita BandyopadhyayD

Non-Executive Independent Women Director

Mr. Hetal Madhukant GandhiD

Non-Executive Independent Director

View all

Incorporated on

20 Nov 1987

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

31 Mar 1995

Free Float

8,72,69,042

Website

https://www.vbshilpa.com/

Phone no.

+918532235006

Address

#12-6-214/A1, Hyderabad Road,, RAICHUR, 584135, India

Frequently Asked Questions

What is the current share price of Shilpa Medicare Ltd.?

The current share price of Shilpa Medicare Ltd. is ₹ 608.95 as of 3 Jul 2026.

What is the market capitalisation of Shilpa Medicare Ltd.?

The market capitalisation of Shilpa Medicare Ltd. stands at ₹ 11,751.50 Cr.

What is the PE ratio of Shilpa Medicare Ltd.?

The Price-to-Earnings (PE) ratio of Shilpa Medicare Ltd. is 48.29 as of the latest trailing twelve months data.

What is the ROE and ROCE of Shilpa Medicare Ltd.?

Shilpa Medicare Ltd. has a Return on Equity (ROE) of 9.80% and a Return on Capital Employed (ROCE) of 8.81% as per the latest financial reports.

What is the 52-week high and low of Shilpa Medicare Ltd.?

The 52-week high of Shilpa Medicare Ltd. is - and the 52-week low is -.

What is the dividend yield of Shilpa Medicare Ltd.?

The dividend yield of Shilpa Medicare Ltd. is 0.08% based on the current market price.

What is the FII and DII holding in Shilpa Medicare Ltd.?

Foreign Institutional Investors (FII) hold 11.08%, Domestic Institutional Investors (DII) hold 7.18% and retail/public investors hold 31.38% of Shilpa Medicare Ltd. shares.

What sector does Shilpa Medicare Ltd. belong to?

Shilpa Medicare Ltd. operates in the Healthcare sector. 100% of analysts have a Buy or Strong Buy rating on Shilpa Medicare Ltd. with a consensus target price of ₹ 580.00, implying 3.47% downside from current levels.

What is the beta of Shilpa Medicare Ltd.?

The beta of Shilpa Medicare Ltd. is 0.87, indicating its price volatility relative to the broader market. Over the past 1 year, Shilpa Medicare Ltd. has delivered an absolute return of 39.08%.

What is the RSI of Shilpa Medicare Ltd.?

The 14-day Relative Strength Index (RSI) of Shilpa Medicare Ltd. is 63.68, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Shilpa Medicare Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Shilpa Medicare Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Holdings and Presence

Corporate Actions